Pluri Inc. (TLV: PLUR)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,550.00
+1.00 (0.06%)
Jan 19, 2025, 3:49 PM IDT
-5.40%
Market Cap 85.55M
Revenue (ttm) 2.22M
Net Income (ttm) -81.07M
Shares Out n/a
EPS (ttm) -15.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,232
Average Volume 7,946
Open 1,549.00
Previous Close 1,549.00
Day's Range 1,545.00 - 1,562.00
52-Week Range 1,535.00 - 2,900.00
Beta n/a
RSI 35.43
Earnings Date Feb 7, 2025

About Pluri

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and a novel immunotherapy platform. The company’s product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acut... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 118
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol PLUR
Full Company Profile

Financial Performance

In 2024, Pluri's revenue was $326,000, an increase of 13.59% compared to the previous year's $287,000. Losses were -$20.89 million, -26.25% less than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.